BlackRock’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9M | Buy |
|
|||||
|
2025
Q1 | $59.3M | Sell |
|
|||||
|
2024
Q4 | $36.7M | Buy |
|
|||||
|
2024
Q3 | $30.6M | Buy |
|
|||||
|
2024
Q2 | $23.2M | Buy |
|
|||||
|
2024
Q1 | $22M | Sell |
|
|||||
|
2023
Q4 | $23.5M | Buy |
|
|||||
|
2023
Q3 | $17.4M | Buy |
|
|||||
|
2023
Q2 | $24.5M | Buy |
|
|||||
|
2023
Q1 | $13.7M | Sell |
|
|||||
|
2022
Q4 | $11.4M | Buy |
|
|||||
|
2022
Q3 | $12.8M | Buy |
|
|||||
|
2022
Q2 | $12.3M | Buy |
|
|||||
|
2022
Q1 | $5.11M | Buy |
|
|||||
|
2021
Q4 | $5.26M | Buy |
|
|||||
|
2021
Q3 | $3.74M | Sell |
|
|||||
|
2021
Q2 | $6.86M | Sell |
|
|||||
|
2021
Q1 | $17M | Buy |
|
|||||
|
2020
Q4 | $17.9M | Buy |
|
|||||
|
2020
Q3 | $21M | Buy |
|
|||||
|
2020
Q2 | $7.49M | Buy |
|
|||||
|
2020
Q1 | $4.55M | Buy |
|
|||||
|
2019
Q4 | $15.5M | Buy |
|
|||||
|
2019
Q3 | $20.9M | Sell |
|
|||||
|
2019
Q2 | $24.5M | Buy |
|
|||||
|
2019
Q1 | $18M | Buy |
|
|||||
|
2018
Q4 | $11M | Buy |
|
|||||
|
2018
Q3 | $6.93M | Buy |
|
|||||
|
2018
Q2 | $475K | Buy |
|